Infectious Disease CE Activities

RMEI DECISION SUPPORT AIDS

View Details

Navigating Nontuberculous Mycobacteria Lung Disease

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients. Nontuberculous mycobacterial lung disease (NTM-LD) is challenging and often delayed due to non-specific symptoms, indolent disease course, and similarities to tuberculosis and other lung diseases; several barriers to its treatment also persist.
View Details

Diagnostic and Susceptibility Testing for Nontuberculous Mycobacterial Lung Diseases

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients. Nontuberculous mycobacterial lung disease (NTM-LD) is a challenging infection that is becoming increasingly prevalent and continues to be a growing concern.
View Details

Considering Therapies for Influenza Treatment and Post-Exposure in Children

This Decision Support Aid serves as a quick reference to help clinicians apply information to their daily practice and care of patients.

LATEST INFECTIOUS DISEASE ARTICLES

RSS feed: Latest Infectious Disease Articles Latest Infectious Disease Articles
  • Case 33-2026: A 73-Year-Old Woman with Fever, Weight Loss, and Leg Weakness November 19, 2026
    A 73-year-old woman presented with fever, weight loss, and leg weakness. A chest radiograph showed biapical pleural and parenchymal scarring and diffuse reticular opacities. A diagnosis was made.
    Michael P. Janjigian, Monica Cheng, Cory A. Perugino, Jonathan S. Hausmann
  • Double Take: Closing the Gap November 19, 2026
    This Double Take video reviews the differential diagnosis for a woman with fever and recurrent sinonasal symptoms and how it evolves as new clinical findings are presented.
    Lakshmi Ravindra, Kimberly Knoper, Nadine Tan, Caren G. Solomon
  • Slightly Alive — Improving Antituberculosis Therapy November 19, 2026
    Tuberculosis is an ancient scourge that remains a modern challenge. Despite the availability of good treatment for drug-susceptible disease, an enormous number of deaths still occur worldwide. Although there are many reasons for this disparity, two are related to our current standard four-drug regimen for drug-susceptible pulmonary tuberculosis (isoniazid, rifampin,...
    Eric J. Rubin

RMEI LIGHTNING TALKS

View Details

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.
View Details

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.

Previously Published CE Activities